Journal article
Biomedicine & Pharmacotherapy, vol. 130, 2020, p. 110592
          APA  
          
            Click to copy
          
          De Souza, P. C., Fernandes, G. F. S., Marino, L. B., Ribeiro, C. M., Da Silva, P. B., Chorilli, M., … Pavan, F. R. (2020). Furoxan derivatives demonstrated in vivo efficacy by reducing Mycobacterium tuberculosis to undetectable levels in a mouse model of infection. Biomedicine &Amp; Pharmacotherapy, 130, 110592. https://doi.org/10.1016/j.biopha.2020.110592
        
          Chicago/Turabian  
          
            Click to copy
          
          De Souza, P.C., G.F.S. Fernandes, L.B. Marino, C.M. Ribeiro, P.B. Da Silva, M. Chorilli, C.S.P. Silva, et al. “Furoxan Derivatives Demonstrated in Vivo Efficacy by Reducing Mycobacterium Tuberculosis to Undetectable Levels in a Mouse Model of Infection.” Biomedicine & Pharmacotherapy 130 (2020): 110592.
        
          MLA  
          
            Click to copy
          
          De Souza, P. C., et al. “Furoxan Derivatives Demonstrated in Vivo Efficacy by Reducing Mycobacterium Tuberculosis to Undetectable Levels in a Mouse Model of Infection.” Biomedicine &Amp; Pharmacotherapy, vol. 130, 2020, p. 110592, doi:10.1016/j.biopha.2020.110592.
        
BibTeX Click to copy
@article{de2020a,
  title = {Furoxan derivatives demonstrated in vivo efficacy by reducing Mycobacterium tuberculosis to undetectable levels in a mouse model of infection},
  year = {2020},
  journal = {Biomedicine & Pharmacotherapy},
  pages = {110592},
  volume = {130},
  doi = {10.1016/j.biopha.2020.110592},
  author = {De Souza, P.C. and Fernandes, G.F.S. and Marino, L.B. and Ribeiro, C.M. and Da Silva, P.B. and Chorilli, M. and Silva, C.S.P. and Resende, F.A. and Solcia, M.C. and De Grandis, R.A. and Costa, C.A.S. and Cho, S.H. and Wang, Y. and Franzblau, S.G. and Dos Santos, J.L. and Pavan, F.R.}
}